{"disease":{"id":"chronic-kidney-disease-ckd","name":"chronic kidney disease ckd"},"drugs":{"marketed":[{"drug_id":"canagliflozin","indication_name":"Chronic kidney disease (CKD) associated with type 2 diabetes (T2D)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Invokana","generic_name":"CANAGLIFLOZIN","company_name":"Johnson & Johnson","drug_phase":"marketed","molecular_target":"Sodium/glucose cotransporter 2","drug_class":"Sodium-Glucose Cotransporter 2 Inhibitor","quality_score":71,"revenue":"800","mechanism":"Invokana works by blocking the SGLT2 protein in the kidneys to reduce glucose reabsorption."},{"drug_id":"finerenone","indication_name":"Chronic kidney disease (CKD) associated with type 2 diabetes (T2D)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Kerendia","generic_name":"FINERENONE","company_name":"Bayer","drug_phase":"marketed","molecular_target":"Mineralocorticoid receptor","drug_class":"Nonsteroidal Mineralocorticoid-Receptor Antagonist [EPC]","quality_score":59,"revenue":"600","mechanism":"Kerendia works by blocking the mineralocorticoid receptor, a protein that regulates sodium and potassium levels in the body."},{"drug_id":"difelikefalin","indication_name":"Pruritus associated with chronic kidney disease (CKD-aP)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Korsuva","generic_name":"DIFELIKEFALIN","company_name":"Vifor Intl","drug_phase":"marketed","molecular_target":"Kappa-type opioid receptor","drug_class":"Kappa Opioid Receptor Agonist","quality_score":48,"revenue":null,"mechanism":"Korsuva works by activating the kappa-type opioid receptor, which helps to reduce itching."}],"pipeline":[],"offLabel":[],"totalMarketed":3,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06769646","title":"SPRING - Assess the Clinical Care Pathway of Population With T2D and CKD in Four European Countries Using Real-world Data","phase":"","overall_status":"COMPLETED","enrollment_count":110074,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT07381101","title":"Trazodone and the Risk of Serious Adverse Events","phase":"","overall_status":"COMPLETED","enrollment_count":31459,"lead_sponsor_name":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","has_results":false},{"nct_id":"NCT07098078","title":"Domperidone and the Risk of Serious Adverse Events","phase":"","overall_status":"COMPLETED","enrollment_count":15000,"lead_sponsor_name":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","has_results":false},{"nct_id":"NCT07274228","title":"Tamsulosin and the Risk of Serious Adverse Events","phase":"","overall_status":"COMPLETED","enrollment_count":14000,"lead_sponsor_name":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","has_results":false},{"nct_id":"NCT07179978","title":"Lorazepam and the Risk of Serious Adverse Events","phase":"","overall_status":"COMPLETED","enrollment_count":12308,"lead_sponsor_name":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","has_results":false},{"nct_id":"NCT07274241","title":"Escitalopram and the Risk of Serious Adverse Events","phase":"","overall_status":"COMPLETED","enrollment_count":12145,"lead_sponsor_name":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","has_results":false},{"nct_id":"NCT07106879","title":"Non-interventional Pre-screening Protocol Aims to Evaluate Participants for Potential Trial Eligibility in Future Clinical Trials/Studies Focusing on Metabolic and Psychiatric Health.","phase":"","overall_status":"RECRUITING","enrollment_count":7000,"lead_sponsor_name":"Clindove Research LLC","has_results":false},{"nct_id":"NCT07043166","title":"Cardiovascular-Kidney-Metabolic Syndrome in Shanghai Zicitizens","phase":"","overall_status":"RECRUITING","enrollment_count":4094,"lead_sponsor_name":"Shanghai Changzheng Hospital","has_results":false},{"nct_id":"NCT04042350","title":"Retrospective Analysis Assessing Clinical Risk Factors for Cardiovascular Events and Mortality and Development of a Risk Calculator in Chronic Kidney Disease Stage 5 on Dialysis","phase":"","overall_status":"COMPLETED","enrollment_count":2773,"lead_sponsor_name":"Astellas Pharma Europe Ltd.","has_results":false},{"nct_id":"NCT06794567","title":"Genomic First Testing in Chronic Kidney Disease","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":2400,"lead_sponsor_name":"Dervla Connaughton","has_results":false},{"nct_id":"NCT01950819","title":"Advancing Renal TRANSplant eFficacy and Safety Outcomes With an eveRolimus-based regiMen (TRANSFORM)","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":2037,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT06694012","title":"Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Osaka Metropolitan University","has_results":false},{"nct_id":"NCT06940414","title":"Prevalence and Risk Factors of Hyperkalemia in Non-Dialysis Chronic Kidney Disease Patients in Community","phase":"","overall_status":"RECRUITING","enrollment_count":1890,"lead_sponsor_name":"Xiujuan Zang","has_results":false},{"nct_id":"NCT06589791","title":"A Disease Area Study on the Awareness and Perceptions of Systemic Inflammation and hsCRP as a biomARKer in Patients With ASCVD and CKD in China Among Cardiologists and Nephrologists","phase":"","overall_status":"COMPLETED","enrollment_count":1500,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT07382960","title":"Pramipexole and the Risk of Serious Adverse Events","phase":"","overall_status":"COMPLETED","enrollment_count":1100,"lead_sponsor_name":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","has_results":false},{"nct_id":"NCT06203704","title":"Observational Secondary Data Study Describing Treatment With Dapagliflozin Among Adult Chronic Kidney Disease Patients","phase":"","overall_status":"COMPLETED","enrollment_count":1086,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT04008810","title":"Serum Neutrophil Gelatinase-associated Lipocalins (NGAL) and Chronic Kidney Disease","phase":"","overall_status":"COMPLETED","enrollment_count":1032,"lead_sponsor_name":"Hillerod Hospital, Denmark","has_results":false},{"nct_id":"NCT06677489","title":"CKD-Heart: Heart Failure Prediction in Asian CKD Patients","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Mackay Memorial Hospital","has_results":false},{"nct_id":"NCT06906627","title":"Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)","phase":"NA","overall_status":"RECRUITING","enrollment_count":750,"lead_sponsor_name":"Duke University","has_results":false},{"nct_id":"NCT05746559","title":"ARTEMIS: Ravulizumab to Protect Patients With CKD From CSA-AKI and MAKE","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":736,"lead_sponsor_name":"Alexion Pharmaceuticals, Inc.","has_results":false},{"nct_id":"NCT05755373","title":"A Multinational Survey-based Study to Understand the Real-world Awareness and Perceptions of Systemic inFLAMmation and rolE of hsCRP as a Biomarker in Patients With AtheroSclerotic CardioVascular Disease and Chronic Kidney Disease Among Cardiologists","phase":"","overall_status":"COMPLETED","enrollment_count":602,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT07023016","title":"Comparative Assessment of Efficacy & Safety of Sacubitril/Valsartan Versus Ramipril in Patients With Renal Dysfunction Hospitalized With Acute Decompensated Heart Failure","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":515,"lead_sponsor_name":"National Heart Institute, Egypt","has_results":false},{"nct_id":"NCT07030595","title":"AP301 Efficacy and Safety in Chinese Dialysis Patients With Hyperphosphatemia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":474,"lead_sponsor_name":"Alebund Pharmaceuticals","has_results":false},{"nct_id":"NCT04707768","title":"Study Evaluating the Efficacy and Safety of Dose Conversion From a Long-acting Erythropoiesis-stimulating Agent (Mircera®) to Three Times Weekly Oral Vadadustat for the Maintenance Treatment of Anemia in Hemodialysis Subjects","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":456,"lead_sponsor_name":"Akebia Therapeutics","has_results":true},{"nct_id":"NCT02504294","title":"A Phase 3b Study of Erythropoietin Drugs Using a Specified Dosing Algorithm in Patients With Chronic Kidney Disease on Hemodialysis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":432,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT06906640","title":"Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)","phase":"NA","overall_status":"RECRUITING","enrollment_count":420,"lead_sponsor_name":"Duke University","has_results":false},{"nct_id":"NCT06944236","title":"CKM Syndrome Prevalence and Its Association With SCORE-2 and BRI","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":400,"lead_sponsor_name":"University of Gaziantep","has_results":false},{"nct_id":"NCT06781294","title":"SIRAKI 02 Posthoc Analysis.","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":343,"lead_sponsor_name":"Hospital Universitari de Bellvitge","has_results":false},{"nct_id":"NCT06819527","title":"Medication Reconciliation in Hospitalized CKD Patients : A Quasi-Experimental Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":323,"lead_sponsor_name":"Jordan University of Science and Technology","has_results":false},{"nct_id":"NCT06976177","title":"Study of MT1013 Injection for the Treatment of Secondary Hyperparathyroidism (SHPT) Patients With Chronic Kidney Disease Undergoing Maintenance Dialysis","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":310,"lead_sponsor_name":"Shaanxi Micot Pharmaceutical Technology Co., Ltd.","has_results":false},{"nct_id":"NCT06675396","title":"Pharmacogenomics of Mood Disorder in Chronic Kidney Disease Patients","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":300,"lead_sponsor_name":"Wonju Severance Christian Hospital","has_results":false},{"nct_id":"NCT06322641","title":"A Study to Understand the Real-world Awareness and Perceptions of Systemic inFLAMmation and rolE of hsCRP as a Biomarker in Patients With AtheroSclerotic CardioVascular Disease and Chronic Kidney Disease Among Nephrologists","phase":"","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT07391904","title":"Patient-centered Precision Medicine Lab Result Communication for Older Adults","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":255,"lead_sponsor_name":"University of California, Los Angeles","has_results":false},{"nct_id":"NCT05465044","title":"Incremental Hemodialysis for Veterans in the First Year of Dialysis (IncHVets)","phase":"NA","overall_status":"RECRUITING","enrollment_count":252,"lead_sponsor_name":"VA Office of Research and Development","has_results":false},{"nct_id":"NCT06607913","title":"Exercise and Monitoring With Post-Hospitalization Muscle Atrophy to Sustain Intrinsic Capacity and Strength","phase":"NA","overall_status":"RECRUITING","enrollment_count":250,"lead_sponsor_name":"VA Office of Research and Development","has_results":false},{"nct_id":"NCT03226899","title":"A Phase 4 Safety and Efficacy Study to Evaluate Lesinurad 200 mg in Participants With Gout and Renal Impairment","phase":"PHASE4","overall_status":"TERMINATED","enrollment_count":242,"lead_sponsor_name":"Ironwood Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT06962891","title":"Validation of a Proteomic Biomarker to Predict Progression of Chronic Kidney Disease","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":213,"lead_sponsor_name":"Angel Argiles","has_results":false},{"nct_id":"NCT07209527","title":"Truway Diagnostic Tools in Primary Care","phase":"EARLY_PHASE1","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":200,"lead_sponsor_name":"Truway Health, Inc.","has_results":false},{"nct_id":"NCT06780865","title":"Protecting Renal Function in Chronic Kidney Disease Patients with Isolated Nighttime Hypertension","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":200,"lead_sponsor_name":"Shanghai Institute of Hypertension","has_results":false},{"nct_id":"NCT06639685","title":"Multi-parametric Functional MRI in Patients of Chronic Kidney Disease","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":200,"lead_sponsor_name":"The First Affiliated Hospital with Nanjing Medical University","has_results":false},{"nct_id":"NCT05422755","title":"The Clinical Study to Evaluate Immunogenicity of Epodion® in Anemia Associated With CKD Patients","phase":"","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"PT. Daewoong Infion","has_results":false},{"nct_id":"NCT06202235","title":"Multifrequency MRE in Evaluation of Chronic Kidney Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Shengjing Hospital","has_results":false},{"nct_id":"NCT04616612","title":"Medication Adherence Given Individual SystemCHANGE(TM) in Advancing Nephropathy (MAGICIAN) Pilot Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"Indiana University","has_results":true},{"nct_id":"NCT04689074","title":"Establishment of the Human Intestinal and Salivary Microbiota Biobank - Kidney Diseases","phase":"","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari","has_results":false},{"nct_id":"NCT06591702","title":"Investigation of the Validity, Reliability, and Responsiveness of BETY-BQ in Chronic Kidney Disease, on Dialysis, and Kidney Transplantation","phase":"","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"Hacettepe University","has_results":false},{"nct_id":"NCT06841016","title":"Virtual Nephrologist","phase":"NA","overall_status":"COMPLETED","enrollment_count":148,"lead_sponsor_name":"University of Pennsylvania","has_results":false},{"nct_id":"NCT06865456","title":"Predictors of Survival of DKD Patients in Assiut University Hospital","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":129,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT06568991","title":"The Effect of Low-protein Rice on Nutritional Status and Other Outcomes of Patients With Chronic Kidney Disease.(KS01)","phase":"NA","overall_status":"COMPLETED","enrollment_count":127,"lead_sponsor_name":"Kaohsiung Medical University Chung-Ho Memorial Hospital","has_results":false},{"nct_id":"NCT04094831","title":"Community-based Screening of Chronic Kidney Disease (CKD) and Measure the Impact of Health Education","phase":"NA","overall_status":"UNKNOWN","enrollment_count":126,"lead_sponsor_name":"International Centre for Diarrhoeal Disease Research, Bangladesh","has_results":false},{"nct_id":"NCT06698614","title":"MEMRI and Kidney Disease","phase":"","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"University of Edinburgh","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}